Public-registry site landscape for NCT07730125, a HR-positive, HER2-negative Breast Cancer study sponsored by CoRegen, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT07730125 (registry record) |
| Sponsor | CoRegen, Inc. |
| Condition(s) | HR-positive, HER2-negative Breast Cancer; TNBC - Triple-Negative Breast Cancer; Prostate Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 0 |
Eichor generates a preliminary site-risk snapshot for NCT07730125 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →